Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | CTSG | P08311 | 1/20 | 0.33 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 2/20 | 0.32 |
| ▸ | IDO1 | P14902 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4917459 | 0.81 | SIRT1 (0.38) | SIRT2SIRT1FDPSGRM5ELANE | |
| SCHEMBL4914804 | 0.70 | ELANE (0.63) | SIRT2SIRT1CYP3A4CYP2C19FDPS | |
| SCHEMBL4923566 | 0.67 | SIRT2 (0.40) | SIRT2SIRT1 | |
| SCHEMBL4918740 | 0.66 | SIRT2 (0.36) | SIRT2SIRT1CYP3A4CYP2C19FDPS | |
| SCHEMBL4919786 | 0.65 | GAA (0.36) | SIRT2SIRT1FDPSHPGDGAA | |
| SCHEMBL4923661 | 0.64 | SIRT2 (0.48) | SIRT2SIRT1L3MBTL1 | |
| SCHEMBL10751909 | 0.63 | BRD4 (0.43) | SIRT2SIRT1CYP3A4CYP2C19FDPS | |
| SCHEMBL4919164 | 0.62 | MAPK1 (0.39) | SIRT2SIRT1FDPSHPGDLMNA | |
| SCHEMBL29565534 | 0.61 | — | — | |
| SCHEMBL39547 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080274892-A1 | Novel Haloalkylsulfonanilide Derivative, Herbicide, and Method of Use Thereof | NIHON NOHYAKU CO., LTD. (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1852425-A1 | NOVEL HALOALKYLSULFONANILIDE DERIVATIVE, HERBICIDE, AND METHOD OF USE THEREOF | Nihon Nohyaku Co., Ltd. (JP) | 2007-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080274892-A1 | Novel Haloalkylsulfonanilide Derivative, Herbicide, and Method of Use Thereof | HDHD5, DDT, CBR3 | SIRT2 1134/4885SIRT1 1312/4885CYP3A4 1140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.